-
Aldo-keto reductase family 1 member B10 prevents esophageal squamous cell carcinoma from reactive carbonyl species-induced cell death and promotes its progression.
Cancer Cell International 2024 Dec; 24(1):425.
Application：IHC, Human, ESCC tumor tissue
-
CHMP2B promotes CHMP7 mediated nuclear pore complex injury in sporadic ALS.
Acta Neuropathologica Communications 2024 Dec; 12(1):199.
Application：IS, Human, iPSNs
-
CHMP2B promotes CHMP7 mediated nuclear pore complex injury in sporadic ALS.
Acta Neuropathologica Communications 2024 Dec; 12(1):199.
Application：IS, Human, iPSNs
-
ACSL3 is an unfavorable prognostic marker in cholangiocarcinoma patients and confers ferroptosis resistance in cholangiocarcinoma cells.
NPJ Precision Oncology 2024 Dec; 8(1):284.
Application：IF, Human, KKU-213B, RMCCA-1 cells
-
An adenoviral vector encoding an inflammation-inducible antagonist, HMGB1 Box A, as a novel therapeutic approach to inflammatory diseases.
mBio 2024 Dec; 0:e0338724.
Application：WB, Human, HEK-293A cells
-
Multi-level analysis of gut microbiome extracellular vesicles-host interaction reveals a connection to gut-brain axis signaling.Product
Microbiology Spectrum 2024 Dec; 0:e0136824.
Application：ELISA, Bacteria, Culture supernatants
-
CD91-mediated reprogramming of DCs by immunogenic heat shock proteins requires the kinases AXL and Fgr.
Cell Communication and Signaling : CCS 2024 Dec; 22(1):598.
Application：WB, Mice, BMDCs cell
-
Functional omics of ORP7 in primary endothelial cells.
BMC Biology 2024 Dec; 22(1):292.
Application：WB, Human, HUVECs cell line
-
Foxo3-mediated physiological cell competition ensures robust tissue patterning throughout vertebrate development.
Nature Communications 2024 Dec; 15(1):10662.
Application：IF, Mouse, Embryos
-
Cross-species RNAi therapy via AAV delivery alleviates neuropathic pain by targeting GCH1.
Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. 2024 Dec; 0:e00511.
Application：WB, IHC, Human, Rat, Dorsal root ganglion, HeLa cells
